BioIntelliSense, Inc

📍 Denver, United States👥 109 employees💰 Last funded Aug 2020
Medical Device🌐 biointellisense.com
Website LinkedIn
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical-grade remote care from in-hospital to home. Learn how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services or visit our website at BioIntelliSense.com. 
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in BioIntelliSense, Inc?
BioIntelliSense, Inc has 1 investors on record on gritt.io.
When did BioIntelliSense, Inc last raise funding?
The most recent investment in BioIntelliSense, Inc recorded on gritt.io was in August 2020.
What industry is BioIntelliSense, Inc in?
BioIntelliSense, Inc operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is BioIntelliSense, Inc based?
BioIntelliSense, Inc is headquartered in Denver, United States.